Stevanato Group (NYSE:STVN) drew fresh attention on 4 August 2026 after reporting mixed second quarter results, with higher sales alongside lower net income, and updating its full year 2026 revenue and profit guidance.

Stevanato Group’s latest results came after a period where the stock’s 90 day share price return of 21.52% and 30 day share price return of 9.86% pointed to building upside momentum, even though the 1 year total shareholder return declined 6.43% and the 3 year total shareholder return declined 32.13%.

If this earnings update has you looking beyond Stevanato Group, it could be a good moment to broaden your watchlist with high potential businesses by checking out the 21 top founder-led companies

Stevanato Group’s shares have already moved sharply on the guidance update, which puts you at a fork in the road. Is it more appealing to commit at today’s level or to wait for a more forgiving entry point once the valuation is clearer?

Most Popular Narrative: 14% Undervalued

The most followed narrative on Stevanato Group sees fair value at $24.39, above the last close of $21.06, which sets a constructive tone for long term holders.

The growing prevalence of biologics and novel drug classes (including GLP-1s, mAbs, and biosimilars) is driving robust, increasing demand for Stevanato's high-value containment and delivery solutions, evidenced by high growth rates in these product lines and strong order pipelines from major pharma clients, which supports ongoing revenue expansion.

Want to see what sits behind that outlook for Stevanato Group? The narrative leans heavily on sustained revenue expansion, thicker margins, and a future earnings multiple that assumes real staying power.

Result: Fair Value of $24.39 (UNDERVALUED)

However, Stevanato Group’s story could change if capital spending keeps free cash flow under pressure, or if a few large biopharma customers cut orders.

Another View On Stevanato Group’s Valuation

While the SWS DCF model points to Stevanato Group trading 23.5% below an estimated future cash flow value of $27.53, the stock still sits on a P/E of 36.9x. That is above a fair ratio of 23.7x, which suggests a risk that the market could compress the multiple over time.

For a closer look at how this model works and what could shift the gap between price and estimated value, Look into how the SWS DCF model arrives at its fair value.

Next Steps

If this mixed but generally constructive sentiment on Stevanato Group leaves you undecided, you may want to take a closer look at the details now and shape your own view with the 3 key rewards

Looking for more investment ideas beyond Stevanato Group?

If Stevanato Group is on your radar, do not stop there. Use this moment to widen your opportunity set with a few focused stock ideas from the Simply Wall St screener.

• Spot potential value opportunities early by checking companies highlighted in the 52 high quality undervalued stocks before others catch on.
• Strengthen the quality of your watchlist by reviewing stocks in the solid balance sheet and fundamentals stocks screener (50 results) that combine financial resilience with fundamental support.
• Aim to get ahead of the crowd by reviewing the screener containing 19 high quality undiscovered gems that may not yet be widely followed but still show strong underlying metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.